National and Kapodistrian University of Athens
Ο σφυροβραχιόνιος δείκτης και ο περιπατητικός 24ωρος δείκτης αρτηριακής σκληρίας ως προγνωστικοί παράγοντες καρδιαγγειακών και νεφρικών συμβαμάτων σε ασθενείς με οξύ έμφραγμα του μυοκαρδίου
Abstract
dc:descriptionBackground: The ankle-brachial index (ABI) is a non-invasive tool initially used for diagnosing lower-extremity peripheral artery disease (PAD). It has been demonstrated that ABI is a reliable marker of atherosclerosis in multiple vascular territories, serving as a predictive tool for cardiovascular events regardless of the presence or absence of PAD symptoms. Another non-invasive index, the ambulatory arterial stiffness index (AASI), deriving from 24-hour blood pressure (BP) monitoring, has been demonstrated to predict cardiovascular morbidity and mortality, particularly stroke, independently of other known risk factors. This study aims to evaluate the prognostic value of both ABI and AASI in the context of acute myocardial infarction (AMI), as there is currently insufficient evidence on their combined role in this setting. Methods: A single-center observational cohort study was conducted with a 3-year follow-up, enrolling 441 consecutive AMI patients (79% male; mean age 62 years; 67% hypertensives; 30% diabetics; 52% current smokers). ABI was measured using a certified automated device, with an abnormal ABI defined as ≤ 0.9. AASI was calculated from the raw 24-h BP data. The primary endpoint was a composite of all-cause and cardiovascular death, as well as major cardiovascular events, including decompensated heart failure, new acute coronary syndromes, cerebrovascular events, PAD events, and new-onset renal dysfunction. Events were assessed both in-hospital and over a 3-year follow-up period. Results: The median ABI in the cohort was 1.10 (IQR: 1.00–1.18), and 10.4% of patients had an abnormal ABI. In reduced multivariable logistic regression models, abnormal ABI was associated with a threefold increased risk of in-hospital adverse events (OR 2.93, 95% CI: 1.48–5.81, p=0.002). Long-term analysis using Cox regression showed that abnormal ABI independently predicted all-cause mortality (HR 2.88, 95% CI: 1.53–5.42, p=0.001), irrespective of hypertension, diabetes, low-density lipoprotein (LDL) levels, and smoking status. Furthermore, each 0.1 increase in AASI was associated with a 21% higher risk of the composite outcome (HR 1.21, 95% CI: 1.08–1.35, p=0.001) and a 25% higher risk of developing a recurrent myocardial infarction or urgent coronary revascularization (HR 1.25, 95% CI: 1.09–1.43, p=0.001). Conclusions: An impaired ABI is strongly associated with increased in-hospital events and long-term all-cause mortality in AMI patients, independent of traditional risk factors. These findings suggest that both subclinical and clinical PAD are linked to poor outcomes in AMI patients, underscoring the importance of routine ABI testing for enhanced risk stratification. Additionally, our results highlight the previously underexplored yet clinically relevant contribution of AASI in the setting of acute myocardial infarction. Further multicenter studies are needed to validate these findings and assess their applicability across diverse populations.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koumelli, Areti
- Κουμέλλη, Αρετή
Subjects
dc:subject × 18- Σφυροβραχιόνιος δείκτης
- Περιπατητικός 24ωρος δείκτης αρτηριακής σκληρίας
- Προγνωστικοί παράγοντες
- Καρδιαγγειακά συμβάματα
- Νεφρικά συμβάματα
- Οξύ έμφραγμα μυοκαρδίου
- Ankle-brachial index
- 24-hour Ambulatory arterial stiffness index
- Prognostic value
- Cardiovascular outcomes
- Renal outcomes
- Acute myocardial infarction
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61030